RTN4 and myeloid sarcoma: Considering that both proteins are markers of neurodegeneration and reflect other pathomechanisms underlying this disease, we calculated the NfL/RTN4 ratio to determine if these mutually complementary proteins in MS could be a valuable diagnostic tool.